FCP OP MEDICAL BioHealth Trends FCP OP ... - Sal. Oppenheim
FCP OP MEDICAL BioHealth Trends FCP OP ... - Sal. Oppenheim
FCP OP MEDICAL BioHealth Trends FCP OP ... - Sal. Oppenheim
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
STOCKPICKING AND PORTFOLIO STRUCTURE<br />
Portfolio structure by product status<br />
Companies with<br />
products on the<br />
market a e<br />
39,0 %<br />
Companies with<br />
products on the<br />
market and<br />
profitable<br />
26,0 %<br />
PRODUCT STATUS INDUSTRIES<br />
Share of fund assets<br />
Cash<br />
1,0 %<br />
Products in early<br />
clinical phase<br />
10,0 %<br />
Products in phase<br />
III and in approval<br />
process<br />
24,0 %<br />
Share of fund assets (%)<br />
Biotechnology 49,1<br />
Emerging Pharma 34,0<br />
Emerging Medtech 14,7<br />
Healthcare Services 1,2<br />
Cash 1,0<br />
Total 100,0<br />
Source: Medical Strategy GmbH, Gräfelfing near Munich<br />
As of: 06/30/2012<br />
The fund’s investment strategy can be changed at any time within the legal and contractual limits. Details of these limits can be found in the sales prospectus.<br />
Focus on companies close to the market<br />
06/30/2012| Page 30 <strong>Oppenheim</strong> Asset Management Services S.à r.l.
Change language